V t The present study was undertaken to examine the ability of a single large intravenous dose of methylprednisolone (15, 30, or 60 mg/kg) to attenuate lipid peroxidation and enhance (Na § + K+)-ATPase activity during the 1st hour after a 400 gm-cm injury to the cat spinal cord. The contusion injury was associated with a rise in the concentration of fluorescent lipid peroxy products in the injured segment at 1 hour. In addition, the accumulation of cyclic guanosine 3',5'-monophosphate (cyclic GMP), which was used as a new index of inj ury-induced free radical reactions, in the injured spinal segment was twice control levels. The injury-induced increase in fluorescence and cyclic GMP content in the contused spinal segment at 1 hour was completely prevented by the administration of 15 or 30 mg/kg of methylprednisolone at 30 minutes after injury. A 60-mg/kg dose, however, did not prevent the elevation in cyclic GMP. A concomitant examination of the acute effects of glucocorticoid administration on (Na + + K+)-ATPase activity in the injured cord revealed a striking increase of enzyme activity after the 30-mg/kg dose, but a depression in activity with the 60-mg/kg dose. These results demonstrate that a single massive dose of methylprednisolone can beneficially reduce free-radical reactions and lipid peroxidation as well as enhance the activity of neuronal (Na + + K+)-ATPase during the early phase after spinal cord contusion. The requirement for doses to be in the range of 15 to 30 mg/kg in order to produce these neurochemical changes is consistent with other studies that have demonstrated significantly greater recovery and tissue preservation in spinal cord-injured animals treated with comparable doses of methylprednisolone soon after injury. These findings suggest the need for a rigorous approach to glucocorticoid therapy in central nervous system trauma.
G
LUCOCORTICOIDS, especially dexamethasone and methylprednisolone, have enjoyed tremendous popularity in the acute treatment of human spinal cord trauma. To a great extent, their use has been based on the results of several experimental studies which have shown enhanced sensorimotor recovery after spinal cord injury in animals treated with large doses of glucocorticoids. 2,11,t4,17,zl, 25 The clinical treatment of human spinal cord injury with high doses of glucocorticoid, however, remains empirical. This is largely due to a poor understanding of the mechanism of action of these drugs, as well as a lack of information concerning which dose and treatment regimen will optimally affect the injured cord.
Some of the most impressive recovery results in spinal cord-injured animals have been obtained with methylprednisolone. In those studies, treatment was initiated soon after injury with massive doses of 15 m g / k g z~ or 30 m g / k g 17 and was then gradually tapered over a period of days. Means, et al., 25 demonstrated a highly significant structural preservation in the injured cords of cats treated with methylprednisolone beginning 1 hour after injury and continued for 9 days. Similar tissue preservation has been noted after high-dose dexamethasone treatment. 15,2~ These data strongly suggest that intensive glucocorticoid treatment after spinal cord injury may improve functional recovery by preventing posttraumatic tissue destruction.
A possible molecular mechanism for the beneficial effects of glucocorticoid on the injured central nervous system has been proposed by Demopoulos, et al., 12, 13 and Naftchi, et al. zs They postulated that steroids attenuate the peroxidation of polyunsaturated fatty acids in myelin, neuronal and glial membranes, and vascular endothelium. This lipid peroxidation is believed to be catalyzed by free radicals generated as the result of ischemic hypoxia and hemorrhage. If unchecked, the peroxidation of spinal cord lipids can lead to the loss of certain enzyme activities that are critical for the maintenance of neuronal excitability (for instance (Na § + K+)-ATPase activity), and ultimately to tissue dissolution.
Considering this very probable mechanism, recent research in our laboratories has shown that a single large intravenous dose of methylprednisolone sodium succinate does act to attenuate in vitro lipid peroxidation in uninjured cat spinal cord homogenates TM and enhance synaptosomal (Na + + K+)-ATPase activity2 However, a methylprednisolone dose Of at least 15 to 30 mg/kg is required in both cases. The present study details a similar dose-response analysis of the ability of a massive single dose of methylprednisolone administered to cats 30 minutes after a 400 gm-cm contusion of the lumbar spinal cord to decrease lipid peroxidation and increase (Na + + K+)-ATPase activity in the injured segment.
Materials and Methods

Animal Preparation and Spinal Injury
Adult cats of either sex, weighing 1.8 to 4 kg, were anesthetized with alpha chloralose (80 mg/kg intravenously). A tracheotomy was performed and one carotid artery cannulated for blood pressure recording. Positive-pressure ventilation with room air was initiated and neuromuscular paralysis induced with gallamine triethiodide (3 mg/kg intravenously) with supplemental doses given as needed. A dorsal laminectomy exposed the lumbar spinal cord from L-2 to L-5, and a unilateral popliteal fossa dissection exposed a sciatic nerve. The animal w~as placed in the prone position in a Kopf 1780 spinal unit,* and the spinous process of L-1 was clamped to the spinal unit. In addition, Kopf hip spikest were inserted to fix the cat 
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in place, with the animal's back lying parallel to the base of the unit.
Spinal cord injury was produced by delivery of a 400 gm-cm force to the exposed cord at L-3 with the dura intact. A 50-gm stainless steel Teflon-lined weight was dropped 8 cm by a pin release mechanism down a central stainless steel shaft which struck a Teflon impounder. The striking surface of the impounder was circular and fiat with a diameter of 6 mm to insure an evenly distributed injury force. At 1 hour after injury, the 6-mm injured cord segment was removed, immediately frozen in liquid nitrogen, and stored at -70~ for biochemical analysis no more than 48 hours later. "Normal" lumbar cord segments were similarly taken from surgically prepared uninjured animals.
The neurophysiological status of the spinal cord was assessed before and after the 400 gm-cm contusion and for the duration of the experiment by monitoring dorsal column evoked potentials. Supramaximal square-wave stimuli of 0.4-msec duration were applied unilaterally to the exposed sciatic nerve at a frequency of 1 Hz using a pair of bipolar platinumiridium hook electrodes. The resulting evoked response was recorded with a second pair of straight bipolar electrodes gently pressing on the dorsal surface of the dura at the L-1 level ipsilateral to the stimulated sciatic nerve. The focus of attention was on the shortlatency sharply evolved spike of the evoked response, which represented the straight axonal (that is, nonsynaptic) conduction from the sensory afferent fibers in the sciatic nerve through the ipsilateral fasciculus gracilis.
Immediately before, and at 2, 30, and 60 minutes after the contusion, a series of 100 consecutive evoked responses were averaged and photographed on a Tracor-Northern 1505 signal averager.~ Figure 1 upper shows examples of dorsal column evoked potentials before and 2 minutes after a 400 gm-cm impact. The completeness of the 400 gm-cm injury was verified by a total abolition of the dorsal column evoked response. Figure 1 lower shows the typical blood pressure elevation at the time of lumbar cord contusion.
Measurement of Fluorescent Lipid Peroxy Products
Fluorescent lipid peroxy products were extracted by homogenizing a weighed portion of spinal cord tissue (approximately 100 mg) in 2 ml of a 2:1 mixture of chloroform and methanol, followed by incubation for 3 minutes at 37~ as described by Chow, et a12 Then 2 ml of water was added, and the mixture centrifuged to separate the chloroform-aqueous phase. The chloroform phase was transferred to a clean tube and the fluorescence measured, using an excitation wavelength of 365 nm with an emission at 460 nm. Fluorescence was compared to a quinine :~ Tracor-Northern 1505 signal averager manufactured by Tracor-Northern, Middleton, Wisconsin. 
Measurement of Cyclic GMP Levels
For determination of cyclic guanosine Y,5'-monophosphate (cyclic GMP) content in spinal cord tissue, a 10-to 50-mg sample of cord was homogenized in 1 ml of 5% trichloroacetic acid (TCA). The homogenate was centrifuged and the TCA supernatant fraction extracted with ether, and acetylated. Cyclic GMP was determined by radioimmunoassay as described elsewhere? ,7 Protein in the TCA pellet was determined by the method of Lowry, et al. 23 Cyclic GMP content was expressed as picomoles per milligram of protein.
Determination of (Na § + K § TPase Activity
A sample of frozen cord, weighing approximately 100 mg, was homogenized in 9 vols of 100 mM Tris-HC1 (pH 7.6) containing 330 mM sucrose. Whole homogenate (Na § + K+)-ATPase activity was determined as described by Braughler and Corder. 4 The ATPase assay (100 #1) was carried out at 37~ in 100 mM imidazole buffer (pH 7.0) containing 6 mM vanadium-free adenosine triphosphate, 6 mM MgC12, 100 mM NaC1, 20 mM KC1, and 0.4 to 1 mg protein/ ml. Reactions were started by the addition of enzyme to the prewarmed reaction mixture and terminated by the addition of 50/zl of 9% perchloric acid at 4~ Inorganic phosphate was determined by the method of Lowry and Lopez. 2e The (Na § + K+)-ATPase activity was determined as the difference between that activity in the absence (total ATPase) and presence (Mg2+-ATPase) of 1 mM ouabain. Protein was determined by the method of Lowry, et al. 23 Activity was expressed as nmoles Pi/mg protein/min. Table 1 shows the effects of a single intravenous dose of mcthylprednisolone (15, 30, or 60 mg/kg), administered 30 minutes after injury, on the formation of fluorescent lipid peroxidation products in the injured spinal cord segment. Untreated and uninjured (normal) cord segments were found to exhibit a basal level of fluorescence which was increased by 16.7% at 1 hour after injury. This increase was not statistically significant. Nevertheless, methylprednisolone produced a dose-related decrease in the formation of fluorescent lipid peroxidation products which was statistically significant (p < 0.05) after the 30-and 60-mg/kg doses.
Effects of Methylprednisolone
Effects on Injury-Induced Free-Radical Reactions and Lipid Per oxidation
A curious aspect of these effects was that the 60-mg/kg dose lowered the fluorescence significantly below the level observed in normal cords. It is unlikely that high doses of methylprednisolone were simply acting to quench fluorescence, since a concentration of methylprednisolone equivalent to the levels found in the uninjured cat spinal cord after a 60-mg/kg dose administered intravenously 6 did not alter the fluorescence of a normal cord sample if added directly into the fluorescent assay. Thus, the decreased fluorescence observed in injured cord samples after highdose methylprednisolone was most likely an in vivo effect.
Although the measurement of fluorescent lipid peroxy products does give some estimate of the degree of lipid peroxidation within tissues, it is, nevertheless, an indirect measure. Fluorescent lipid peroxy compounds are formed in tissues by the conjugation of less stable lipid peroxidation products, such as malonyldialdehyde, with proteins and amino acids. As such, fluorescence is difficult to quantitate and is not a true representation of in vivo peroxidationper se. In an effort to overcome some of these limitations, we decided to examine the usefulness of measuring tissue cyclic G M P content as an index of free radical reactions and lipid peroxidation.
Guanylate cyclase, the enzyme responsible for the synthesis of cyclic G M P in tissues, has been shown to be exquisitely sensitive to activation by free radicals and oxidative events. 7,27 Fatty acid hydroperoxides, prostaglandin endoperoxides, hydroxyl radical, and superoxide anion are among a group of compounds that have been shown to activate guanylate cyclase and increase cyclic G M P in tissues. 16,27,35 Recent studies by Briggs and DeRubertis, s and Spies, et a l . y have demonstrated that the alteration of tissue cyclic G M P content by hormones is linked to the Ca2 § release of fatty acids and their subsequent metabolism to fatty acid oxygenation products. Such information suggests that cyclic G M P accumulation in tissues may be used as an index of free-radical reactions and oxidative processes.
The results from the present study are shown in Table 2 . The 400 gm-cm contusion to the lumbar cord caused a doubling in the cyclic G M P content of the injured segment at 1 hour (p < 0.0001). This increase in cyclic G M P was completely prevented by both the 15-or 30-mg/kg doses of methylprednisolone. On the other hand, the 60-mg/kg dose did not affect the injury-induced elevation of cyclic GMP. Table 3 shows the effects of injury, with or without subsequent methylprednisolone treatment, on (Na + + K+)-ATPase activity in lumbar spinal cord homogenates measured 1 hour after contusion. Injury actually produced a non-significant increase in the (Na § + K § activity of the injured segment. On the other hand, 15-and 30-mg/kg doses of methylprednisolone caused 42.0% and 56.4% increases, respectively, in enzyme activity over that measured in un- treated injured cord homogenates. The increase was significant after the 30-mg/kg dose (p < 0.05). Raising the dose to 60 mg/kg, however, produced an opposite effect, in that the enzyme activity was reduced by 37.6% compared to that obtained in the untreated injured cords (p < 0.05).
Effects on (Na + + K+)-A TPase Activity
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Effects on Arterial Blood Pressure
Administration of a single intravenous bolus injection of methylprednisolone sodium succinate (15, 30, or 60 mg/kg) consistently altered arterial blood pressure. However, the effect was quite variable and relatively short-lived. No pharmacological analysis of the mechanism of the blood pressure effects was conducted. This will be the subject of a future study.
Discussion
The results of this study demonstrate that a single intravenous dose of methylprednisolone can significantly reduce lipid peroxidation and enhance (Na § + K+)-ATPase activity in the acutely injured cat spinal cord. However, the need for massive doses in the range of 15 to 30 mg/kg to achieve these beneficial effects is apparent.
Prior research in our laboratories has shown that a single 30-mg/kg dose of methylprednisolone administered intravenously acts to attenuate in vitro lipid peroxidation in homogenates of cord samples removed 1 hour after glucocorticoid injection. ~8 That study employed the thiobarbituric acid test which measures malonyldialdehyde formation during aerobic incubation of the homogenate. Malonyldialdehyde is a principal breakdown product of peroxidized polyunsaturated fatty acids in spinal myelin, neuronal and glial membranes, and other cellular elements. 29,3~ Malonyldialdehyde readily reacts with other macromolecules (for instance, amino-containing phospholipids, proteins, and amino acids) to form lipofuscin-like fluorescent pigments that are unreactive to thiobarbituric acid. These lipofuscin-like products can be extracted in chloroform and methanol, and are fluorescent when excited at a wavelength of 360 to 370 nm. 9 Fluorescence spectroscopy has been used by Seligman, et al.,a~ to follow lipid peroxidation induced by spinal cord injury from 3 hours to 23 days after injury.
The results of the current study show that spinal cord contusion injury produces a rise in fluorescent lipid peroxidation products in the injured segment as early as 1 hour after injury. Furthermore, the increase is prevented by intravenous methylprednisolone when administered 30 minutes after injury in a massive dose of approximately 30 mg/kg. Presumably, this effect represents an attenuation of injury-induced in vivo lipid peroxidation. A curious aspect of the results, though, is that raising the dose from 30 to 60 mg/kg reduces the measurable lipid fluorescence significantly below the normal baseline levels. While no definitive explanation can be offered at present, the effect has been determined not to be due to in vitro quenching.
The concept relating cyclic GMP accumulation to free-radical reactions and lipid peroxidation in the injured spinal cord represents an exciting new introduction to the field of central nervous system trauma. It is based on extensive studies which have conclusively demonstrated that free radicals and oxidative events can rapidly and directly activate guanylate cyclase, v,27,a5 From the results shown in Table 2 , it is clear that the cyclic GMP content is dramatically increased in the injured segment 1 hour after the 400 gm-cm contusion. The sensitivity of spinal cyclic GMP metabolism to injury, coupled with the high reproducibility and sensitivity of the radioimmunoassay, offers a distinct advantage over the less sensitive and highly variable thiobarbituric acid test or fluorescence spectroscopy for studying injury-induced lipid peroxidation and related events 9 By using cyclic GMP as an index of injury-induced free-radical reactions, it is apparent that single doses of methylprednisolone in amounts of 15 or 30 mg/kg can reduce lipid peroxidation in the injured cord. On the contrary, increasing the dose to 60 mg/kg appears counterproductive 9 This finding is reminiscent of the biphasic dose-response relationship for the effect of intravenous methylprednisolone on in vitro spinal lipid peroxidation. TM It is unlikely that the glucocorticoid decreases injury-induced cyclic GMP formation by directly depressing the responsiveness of guanylate cyclase to free radicals 9 Studies by Vesely 34 have shown that, if anything, glucocorticoids enhance guanylate cyclase activity in a variety of tissues including brain.
In view of the fact that cyclic GMP formation may be a reflection of free-radical reactions, the present data suggest that massive doses of methylprednisolone may reduce lipid peroxidation by affecting the processes that lead to free-radical production. The primary factor in this regard is believed to be the ischemic hypoxia that is secondary to injury-induced vasospasm (see an excellent discussion by Demopoulos, et all2) . Indeed, the recent work of Anderson, et al., 1 has suggested that massive doses of methylprednisolone improve blood flow and oxidative phosphorylation in the cat spinal cord after compression injury. The enhanced oxygen delivery would counteract the hypoxia-related increase in superoxide, hydroxyl radical, and singlet oxygen and the resultant lipid peroxidation.
While it is certain that a methylprednisolone-induced increase in blood flow to the injured cord 1 would serve to decrease free-radical production and lipid peroxidation, the demonstration of a decrease by methylprednisolone in the in vitro formation of lipid peroxides in spinal cord homogenates TM shows an additional glucocorticoid action on lipid peroxidation per se. This view is further supported by the observation that methylprednisolone incorporation decreases lipid peroxidation in ultraviolet-irradiated liposomes, possibly via an antioxidant effect of the glucocorticoid? 1
One of the initial and functionally significant consequences of tissue lipid peroxidation is a decline in the activities of various membrane-bound enzymes. TM For instance, the activity of spinal cord (Na § + K+) -ATPase, which is critically involved in the physiological maintenance of the resting membrane potential, and thus the excitability of neurons, has been shown to be decreased in the core of the injured segment within 5 minutes after injury. This reduced activity is believed to be secondary to damage induced by free radicals. 1~ Furthermore, various in vitro studies have shown an inhibitory effect of lipid peroxidation on synaptosomal (Na + + K+)-ATPase activity, t9,z~ Although the present experiments do not show a decrease in enzyme activity at 1 hour after injury, confirming the findings of Clendenon, et al., 1~ the demonstration of a significant enhancement in the activity of the enzyme in the acutely contused cat spinal cord is of considerable therapeutic relevance 9 These findings also confirm the results of our previous study which showed a similar dose-related increase in (Na § + K+)-ATPase activity measured in synaptosomes prepared from uninjured spinal cord? In both instances, the threshold dose of methylprednisolone appears to be 15 mg/kg. However, in this present study using homogenates prepared at 1 hour after cord trauma, the methylprednisolone effect is biphasic in that the 60-mg/kg dose actually depressed enzyme activity. This result fits well with the biphasic action of the glucocorticoid on cyclic GMP formation and with our previously reported findings demonstrating the effects of moderately high (30 mg/kg) versus very high (60 to 90 mg/kg) doses on in vitro lipid peroxidation. TM Indeed, it is possible that the significant elevation in enzyme activity in the injured cord with the 30-mg/kg dose is related to a decrease in in vivo lipid peroxidation, whereas the depression in activity after the 60-mg/kg dose may be related in part to an increased lipid peroxidation.
These results have implications for the clinical treatment of acute spinal cord trauma with glucocorticoids. The relationship of injury-induced free-radical reactions and the ensuing lipid peroxidation to the secondary pathology and pathophysiology of spinal cord injury has been conclusively demonstrated by Demopoulos and colleagues. 12,26,2s,3~ These investigators have further postulated that the beneficial effects of the glucocorticoids in experimental studies reflect an attenuation of these destructive oxidative phenomena. '2,13,2s The present data confirm this hypothesis and show that massive doses of methylprednisolone in amounts of 15 or 30 mg/kg are required to achieve a significant reduction in injury-induced lipid peroxidation and enhance the activity of the critical neuronal enzyme (Na + + K+)-ATPase. Consistent with this conclusion are the recent results of Green, et al., 17 and Means, et al., 2~ which have clearly demonstrated that early treatment of spinal cord-injured animals with equivalent methylprednisolone doses results in a significant improvement in sensorimotor recovery.
At least two questions now remain in relation to a future rationalization of glucocorticoid therapy of human spinal cord trauma. The first concerns the effects of massive glucocorticoid doses on lipid peroxidation and functional recovery when treatment is initiated at later times after injury. The second relates to the pharmacokinetics of methylprednisolone in the injured cord, together with the time course of its pharmacological effects. This information is required to design the most beneficial maintenance dosing regimen. Other work in our laboratories employing highperformance liquid chromatography 6,24 has shown that methylprednisolone is eliminated from the uninjured spinal cord with a half-life of about 3 hours. Furthermore, the uptake and the time course of elimination approximate the time course of the effects of methylprednisolone on (Na + + K+)-ATPase activity and in vitro lipid peroxidation. 6 These studies have demonstrated the need for rigorous and frequent maintenance dosing to maintain effective tissue concentrations of the drug. Further studies are currently underway to verify these pharmacokinetic and pharmacological relationships in the acutely injured cat spinal cord.
